公司资料
Evelo Biosciences 股价、新闻与催化剂
- 股票代码:
- EVLO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-99.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
Current closing-price context is not available for EVLO.
公司概览
业务概览
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker. Its story was centered on the challenge of turning a novel biology concept into durable human data.
所在地与行业分类
Evelo was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotechnology and immunology.
商业模式特征
The company depended on translational validation, clinical data, and access to capital. Investors historically watched whether the platform could show enough differentiation to survive in a crowded biotech market.
生物医药行业定位
Evelo is best viewed as a historical platform-biotech name. Its valuation was always tied to science proof and capital runway more than commercial scale.
未来催化剂
- Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on what value remains.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。